申请人:ALTANA Pharma AG
公开号:EP1650193A2
公开(公告)日:2006-04-26
Compounds of the formula I,
in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meanings indicated in the description, are novel active bronchial therapeutics.
式 I 的化合物、
其中 R1、R2、R3、R31、R4、R5、R51、R6、R13 和 R20 具有描述中的含义,是新型活性支气管治疗剂。